These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 27903651)
1. T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions. Van de Velde LA; Subramanian C; Smith AM; Barron L; Qualls JE; Neale G; Alfonso-Pecchio A; Jackowski S; Rock CO; Wynn TA; Murray PJ J Biol Chem; 2017 Jan; 292(1):15-30. PubMed ID: 27903651 [TBL] [Abstract][Full Text] [Related]
2. Proliferating Helper T Cells Require Rictor/mTORC2 Complex to Integrate Signals from Limiting Environmental Amino Acids. Van de Velde LA; Murray PJ J Biol Chem; 2016 Dec; 291(50):25815-25822. PubMed ID: 27799302 [TBL] [Abstract][Full Text] [Related]
3. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors. Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727 [TBL] [Abstract][Full Text] [Related]
4. Identification of rictor as a novel substrate of Polo-like kinase 1. Shao T; Liu X Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006 [TBL] [Abstract][Full Text] [Related]
5. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608 [TBL] [Abstract][Full Text] [Related]
6. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
7. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition. Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307 [TBL] [Abstract][Full Text] [Related]
8. Rictor/mammalian target of rapamycin complex 2 promotes macrophage activation and kidney fibrosis. Ren J; Li J; Feng Y; Shu B; Gui Y; Wei W; He W; Yang J; Dai C J Pathol; 2017 Aug; 242(4):488-499. PubMed ID: 28585302 [TBL] [Abstract][Full Text] [Related]
9. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice. Tripathy S; Jump DB J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444 [TBL] [Abstract][Full Text] [Related]
11. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351 [TBL] [Abstract][Full Text] [Related]
12. Down regulation of Peroxiredoxin-3 in 3T3-L1 adipocytes leads to oxidation of Rictor in the mammalian-target of rapamycin complex 2 (mTORC2). Olson DH; Burrill JS; Kuzmicic J; Hahn WS; Park JM; Kim DH; Bernlohr DA Biochem Biophys Res Commun; 2017 Nov; 493(3):1311-1317. PubMed ID: 28986255 [TBL] [Abstract][Full Text] [Related]
13. Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction. Rosborough BR; Raïch-Regué D; Matta BM; Lee K; Gan B; DePinho RA; Hackstein H; Boothby M; Turnquist HR; Thomson AW Blood; 2013 May; 121(18):3619-30. PubMed ID: 23444404 [TBL] [Abstract][Full Text] [Related]
14. mTORC2 in Thymic Epithelial Cells Controls Thymopoiesis and T Cell Development. Wang HX; Cheng JS; Chu S; Qiu YR; Zhong XP J Immunol; 2016 Jul; 197(1):141-50. PubMed ID: 27233961 [TBL] [Abstract][Full Text] [Related]
15. mTORC2 regulates multiple aspects of NKT-cell development and function. Sklarz T; Guan P; Gohil M; Cotton RM; Ge MQ; Haczku A; Das R; Jordan MS Eur J Immunol; 2017 Mar; 47(3):516-526. PubMed ID: 28078715 [TBL] [Abstract][Full Text] [Related]
16. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609 [TBL] [Abstract][Full Text] [Related]
17. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways. Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201 [TBL] [Abstract][Full Text] [Related]
18. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation. Koo J; Wu X; Mao Z; Khuri FR; Sun SY J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W. Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186 [TBL] [Abstract][Full Text] [Related]
20. mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo. Raïch-Regué D; Rosborough BR; Watson AR; McGeachy MJ; Turnquist HR; Thomson AW J Immunol; 2015 May; 194(10):4767-76. PubMed ID: 25840913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]